First advanced course on biomarkers in molecular and immuno-oncology in the Middle East

The first ‘advanced course on biomarkers in molecular and immuno-oncology’ in the Middle East took place in Beirut, Lebanon, as a hybrid meeting on 11 December 2020. The aim of this seminar was to discuss biomarker development, implications and detection modalities and to highlight advances in molec...

Full description

Saved in:
Bibliographic Details
Published in:Future oncology (London, England) England), 2021-08, Vol.17 (22), p.2831-2834
Main Authors: Moujaess, Elissar, Khoury, Makram, Zouein, Joseph, Eid, Josiane Bou, Mohty, Razan, Kourie, Hampig Raphael
Format: Article
Language:English
Subjects:
biomarkers
Biomarkers, Tumor - analysis
conference
Congresses as Topic
course
Humans
immunotherapy
Immunotherapy - methods
Lebanon
Medical Oncology - methods
molecular oncology
Molecular Targeted Therapy - methods
Neoplasms - diagnosis
Neoplasms - immunology
Neoplasms - therapy
targeted therapy
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The first ‘advanced course on biomarkers in molecular and immuno-oncology’ in the Middle East took place in Beirut, Lebanon, as a hybrid meeting on 11 December 2020. The aim of this seminar was to discuss biomarker development, implications and detection modalities and to highlight advances in molecular technologies as well as the clinical applicability of biomarkers in oncology. The seminar consisted of five sessions, each discussing a special topic in the biomarker field. It also included a competition in the form of a quiz following each session. This was followed by a plenary session presented by well-known national and international speakers, highlighting various aspects of biomarkers in immuno-oncology.
ISSN:1479-6694
1744-8301
DOI:10.2217/fon-2021-0192